Yuyu Pharma, Inc.
シンボルマーク: 000225.KS
KSC
4985
KRW今日の市場価格
-11.8661
PER(株価収益率
-0.1679
PEGレシオ
76.98B
MRK キャップ
- 0.00%
DIV利回り
Yuyu Pharma, Inc. (000225-KS) 財務諸表
貸借対照表
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 0 | 30604.9 | 30777.6 | 50263.5 | |||||||||||||||||
balance-sheet.row.short-term-investments | 0 | 1749.3 | 4939.1 | -2909.2 | |||||||||||||||||
balance-sheet.row.net-receivables | 0 | 24454.5 | 25308.8 | 22905.2 | |||||||||||||||||
balance-sheet.row.inventory | 0 | 44152.2 | 39832 | 25225.3 | |||||||||||||||||
balance-sheet.row.other-current-assets | 0 | 2384.9 | 439.3 | 494 | |||||||||||||||||
balance-sheet.row.total-current-assets | 0 | 101596.5 | 96357.7 | 98887.9 | |||||||||||||||||
balance-sheet.row.property-plant-equipment-net | 0 | 81402.7 | 81371.3 | 80341.4 | |||||||||||||||||
balance-sheet.row.goodwill | 0 | 503.2 | 50.8 | 50.8 | |||||||||||||||||
balance-sheet.row.intangible-assets | 0 | 3764.5 | 3666.5 | 4087.1 | |||||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 4267.7 | 3717.3 | 4137.9 | |||||||||||||||||
balance-sheet.row.long-term-investments | 0 | 10815.2 | 1004.7 | 8945 | |||||||||||||||||
balance-sheet.row.tax-assets | 0 | 3764.5 | -1004.7 | -8945 | |||||||||||||||||
balance-sheet.row.other-non-current-assets | 0 | -3633.1 | 13758.7 | 9618.1 | |||||||||||||||||
balance-sheet.row.total-non-current-assets | 0 | 96617 | 98847.3 | 94097.4 | |||||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||||||||||||||||
balance-sheet.row.total-assets | 0 | 198213.5 | 195205.1 | 192985.3 | |||||||||||||||||
balance-sheet.row.account-payables | 0 | 10951.8 | 15840.5 | 8982.3 | |||||||||||||||||
balance-sheet.row.short-term-debt | 0 | 25386.2 | 37425 | 10427.3 | |||||||||||||||||
balance-sheet.row.tax-payables | 0 | 574.8 | 515.4 | 1004.5 | |||||||||||||||||
balance-sheet.row.long-term-debt-total | 0 | 13640 | 1851.4 | 28739.1 | |||||||||||||||||
Deferred Revenue Non Current | 0 | 380.9 | 0 | 2649.5 | |||||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | |||||||||||||||||
balance-sheet.row.other-current-liab | 0 | 12247.1 | 10366.1 | 0 | |||||||||||||||||
balance-sheet.row.total-non-current-liabilities | 0 | 27882.7 | 7515.5 | 34285.5 | |||||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||||||||||||||||
balance-sheet.row.capital-lease-obligations | 0 | 380.9 | 793.8 | 697.8 | |||||||||||||||||
balance-sheet.row.total-liab | 0 | 77857.9 | 71831 | 64300.2 | |||||||||||||||||
balance-sheet.row.preferred-stock | 0 | 2592.5 | 2592.5 | 2592.5 | |||||||||||||||||
balance-sheet.row.common-stock | 0 | 17609.2 | 17609.2 | 17609.2 | |||||||||||||||||
balance-sheet.row.retained-earnings | 0 | 13946.5 | 31395.9 | 36540.4 | |||||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | 25885.4 | 23796 | 24242.5 | |||||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 0 | 52154.1 | 41422.7 | 43296.7 | |||||||||||||||||
balance-sheet.row.total-stockholders-equity | 0 | 112187.6 | 116816.2 | 124281.2 | |||||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 0 | 198213.5 | 195205.1 | 192985.3 | |||||||||||||||||
balance-sheet.row.minority-interest | 0 | 8168 | 6557.8 | 4403.9 | |||||||||||||||||
balance-sheet.row.total-equity | 0 | 120355.7 | 123374 | 128685.1 | |||||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 0 | - | - | - | |||||||||||||||||
Total Investments | 0 | 10815.2 | 5943.8 | 6035.9 | |||||||||||||||||
balance-sheet.row.total-debt | 0 | 39407.2 | 39276.4 | 39166.5 | |||||||||||||||||
balance-sheet.row.net-debt | 0 | 8802.3 | 13437.8 | -11097 |
キャッシュフロー計算書
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 0 | -7180.9 | -4425.4 | -920.3 | |||||||||||||||||
cash-flows.row.depreciation-and-amortization | 0 | 5607.3 | 5027.4 | 4503 | |||||||||||||||||
cash-flows.row.deferred-income-tax | 0 | 0 | 0 | 2698.8 | |||||||||||||||||
cash-flows.row.stock-based-compensation | 0 | 0 | 0 | -42.4 | |||||||||||||||||
cash-flows.row.change-in-working-capital | 0 | -6772.5 | -13150.7 | -3703.6 | |||||||||||||||||
cash-flows.row.account-receivables | 0 | 918.9 | -1760.7 | -3016.3 | |||||||||||||||||
cash-flows.row.inventory | 0 | -3424.1 | -15133.5 | -1366.8 | |||||||||||||||||
cash-flows.row.account-payables | 0 | -5527.3 | 7090.7 | 3715.8 | |||||||||||||||||
cash-flows.row.other-working-capital | 0 | 1260 | -3347.2 | -3036.3 | |||||||||||||||||
cash-flows.row.other-non-cash-items | 0 | 9185.2 | 6319.7 | 1973.2 | |||||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 0 | 0 | 0 | 0 | |||||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | -5106.2 | -5567.7 | -6750.9 | |||||||||||||||||
cash-flows.row.acquisitions-net | 0 | -770.9 | 4.6 | 1029 | |||||||||||||||||
cash-flows.row.purchases-of-investments | 0 | -606 | -3833.6 | -822.3 | |||||||||||||||||
cash-flows.row.sales-maturities-of-investments | 0 | 3047.3 | 506 | 701.6 | |||||||||||||||||
cash-flows.row.other-investing-activites | 0 | -346.4 | 346.9 | -47 | |||||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | 0 | -3782.2 | -8543.8 | -5889.6 | |||||||||||||||||
cash-flows.row.debt-repayment | 0 | -10449.7 | -6253.3 | -906.8 | |||||||||||||||||
cash-flows.row.common-stock-issued | 0 | 0 | 0 | 0 | |||||||||||||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | -1785.2 | 0 | |||||||||||||||||
cash-flows.row.dividends-paid | 0 | -2001.7 | -2033.7 | -1851.2 | |||||||||||||||||
cash-flows.row.other-financing-activites | 0 | 20160.8 | 989.1 | 34071 | |||||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | 7709.4 | -9083.2 | 31313 | |||||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | 0 | -568.9 | 8.6 | |||||||||||||||||
cash-flows.row.net-change-in-cash | 0 | 4766.3 | -24424.9 | 29940.6 | |||||||||||||||||
cash-flows.row.cash-at-end-of-period | 0 | 30604.9 | 25838.6 | 50263.5 | |||||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 0 | 25838.6 | 50263.5 | 20322.8 | |||||||||||||||||
cash-flows.row.operating-cash-flow | 0 | 839.1 | -6229 | 4508.7 | |||||||||||||||||
cash-flows.row.capital-expenditure | 0 | -5106.2 | -5567.7 | -6750.9 | |||||||||||||||||
cash-flows.row.free-cash-flow | 0 | -4267.1 | -11796.7 | -2242.2 |
損益計算書の行
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 137209.6 | 138881.1 | 115655.5 | |||||||||||||||||
income-statement-row.row.cost-of-revenue | 0 | 90704.5 | 85567.9 | 70320.1 | |||||||||||||||||
income-statement-row.row.gross-profit | 0 | 46505.1 | 53313.1 | 45335.4 | |||||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||||||||||||||
income-statement-row.row.research-development | 0 | - | - | - | |||||||||||||||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | |||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||||||||||||
income-statement-row.row.other-expenses | 0 | -219.2 | 25291.4 | 23750.8 | |||||||||||||||||
income-statement-row.row.operating-expenses | 0 | 47254.1 | 53905.3 | 44135.2 | |||||||||||||||||
income-statement-row.row.cost-and-expenses | 0 | 137958.5 | 139473.2 | 114455.3 | |||||||||||||||||
income-statement-row.row.interest-income | 0 | 896.7 | 561.7 | 201 | |||||||||||||||||
income-statement-row.row.interest-expense | 0 | 2553.8 | 2580.7 | 2175.4 | |||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||||||||||||
income-statement-row.row.total-other-income-expensenet | 0 | -4199.5 | -4502.1 | -3036.7 | |||||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||||||||||||||
income-statement-row.row.other-operating-expenses | 0 | -219.2 | 25291.4 | 23750.8 | |||||||||||||||||
income-statement-row.row.total-operating-expenses | 0 | -4199.5 | -4502.1 | -3036.7 | |||||||||||||||||
income-statement-row.row.interest-expense | 0 | 2553.8 | 2580.7 | 2175.4 | |||||||||||||||||
income-statement-row.row.depreciation-and-amortization | 0 | 5607.3 | 5027.4 | 4503 | |||||||||||||||||
income-statement-row.row.ebitda-caps | 0 | - | - | - | |||||||||||||||||
income-statement-row.row.operating-income | 0 | -748.9 | 691.7 | 2653.5 | |||||||||||||||||
income-statement-row.row.income-before-tax | 0 | -4948.5 | -3810.4 | -383.2 | |||||||||||||||||
income-statement-row.row.income-tax-expense | 0 | 98.4 | 615 | 537.1 | |||||||||||||||||
income-statement-row.row.net-income | 0 | -7180.9 | -4425.4 | -920.3 |
よくある質問
Yuyu Pharma, Inc.000225.KS 総資産とは何ですか?
Yuyu Pharma, Inc. (000225.KS) 総資産は 198213526767.000.
企業の年間売上高とは?
年間収益は N/Aである.
企業の利益率は?
利益率は 0.352 である.
企業のフリーキャッシュフローとは?
フリーキャッシュフローは -285.886.
企業の純利益率は?
純利益率は -0.050 である.
企業の総収入は?
総収入は -0.001 である.
Yuyu Pharma, Inc. (000225.KS) 純利益(純利益)とは何ですか?
純利益(純利益)は -7180899668.000.
負債総額は?
負債合計は 39407153086.000 である.
営業費用はいくらですか?
営業費用は 47254050269.000 である.
会社の現金はいくらですか?
企業の現金は 0.000 である.